9-(5,9-Dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole

Catalog No. :
ACENAQ150
CAS No. :
2170468-48-9
Molecular Formula :
C34H26BNO2
Molecular Weight :
491.40

IUPAC Name:9-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole

9-(5,9-Dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-(5,9-Dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole
IUPAC Name9-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole
Molecular FormulaC34H26BNO2
Molecular Weight491.40
SMILESO1C=2C=CC=CC2B3C=4C=CC=CC4OC5=CC(=CC1=C35)N6C=7C(=CC(=CC7C)C)C=8C=C(C=C(C86)C)C
InChI KeyGNDFWTQHQVXHQB-UHFFFAOYSA-N
Synonym9H-Carbazole, 9-[1,4]benzoxaborino[2,3,4-kl]phenoxaborin-7-yl-1,3,6,8-tetramethyl-;9-[1,4]Benzoxaborino[2,3,4-kl]phenoxaborin-7-yl-1,3,6,8- tetramethyl-9H-carbazole;9-(5,9-Dioxa-13b-boranaphtho[3,2,1-de]anthracen-7-yl)-1,3,6,8-tetramethyl-9H-carbazole
CAS No.2170468-48-9

Synthetic Route by SureRoute

1. ACENAQ150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXCSZ692 route compound structure diagram
    ACXCSZ6926558-85-6 In Stock
  2. Plus
  3. ACLNHR244 route compound structure diagram
    ACLNHR2442262575-00-6 In Stock
  4. Then
  5. ACENAQ150 route product structure diagram
    ACENAQ1502170468-48-9
Inquiry

2. ACENAQ150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQKSS543 route compound structure diagram
    ACQKSS5432489719-59-5 In Stock
  2. Plus
  3. ACXCSZ692 route compound structure diagram
    ACXCSZ6926558-85-6 In Stock
  4. Then
  5. ACENAQ150 route product structure diagram
    ACENAQ1502170468-48-9
Inquiry

Comments (0)